
Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Investment analysts at B. Riley lifted their Q3 2025 earnings estimates for shares of Core Scientific in a note issued to investors on Wednesday, July 9th. B. Riley analyst N. Giles now forecasts that the company will earn $0.00 per share for the quarter, up from their prior forecast of ($0.02). B. Riley currently has a "Hold" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. B. Riley also issued estimates for Core Scientific's Q4 2025 earnings at $0.03 EPS.
Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02. The business had revenue of $79.53 million during the quarter, compared to analyst estimates of $92.04 million. The company's revenue was down 55.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.78 EPS.
CORZ has been the subject of several other research reports. HC Wainwright lowered shares of Core Scientific from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 8th. Craig Hallum lowered shares of Core Scientific from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 7th. Roth Mkm reiterated a "buy" rating and issued a $20.00 price objective on shares of Core Scientific in a research note on Thursday, June 26th. JMP Securities reissued a "market perform" rating and set a $15.00 target price on shares of Core Scientific in a research report on Monday. Finally, Needham & Company LLC downgraded shares of Core Scientific from a "moderate buy" rating to a "hold" rating and set a $18.00 target price for the company. in a research report on Thursday. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Core Scientific has a consensus rating of "Hold" and a consensus price target of $18.22.
Get Our Latest Report on Core Scientific
Core Scientific Stock Performance
NASDAQ:CORZ traded up $1.05 on Friday, hitting $13.56. The stock had a trading volume of 24,592,598 shares, compared to its average volume of 16,627,760. The stock has a market cap of $4.04 billion, a P/E ratio of -2.70 and a beta of 6.71. Core Scientific has a 1 year low of $6.20 and a 1 year high of $18.63. The firm's fifty day simple moving average is $12.22 and its two-hundred day simple moving average is $11.07.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. Wellington Shields & Co. LLC bought a new position in Core Scientific in the 4th quarter valued at $26,000. State of Wyoming bought a new position in Core Scientific in the 1st quarter valued at $34,000. Emerald Mutual Fund Advisers Trust bought a new position in Core Scientific in the 1st quarter valued at $38,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Core Scientific in the 1st quarter valued at $50,000. Finally, CWM LLC raised its position in shares of Core Scientific by 403.9% during the 1st quarter. CWM LLC now owns 8,092 shares of the company's stock valued at $59,000 after buying an additional 6,486 shares in the last quarter.
Insider Activity at Core Scientific
In related news, insider Todd M. Duchene sold 60,000 shares of the firm's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $11.33, for a total value of $679,800.00. Following the completion of the transaction, the insider directly owned 2,100,102 shares of the company's stock, valued at approximately $23,794,155.66. This trade represents a 2.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Yadin Rozov acquired 110,000 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was acquired at an average cost of $10.87 per share, with a total value of $1,195,700.00. Following the completion of the acquisition, the director owned 475,687 shares in the company, valued at $5,170,717.69. This trade represents a 30.08% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 117,759 shares of company stock valued at $1,391,434. 1.40% of the stock is owned by insiders.
About Core Scientific
(
Get Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Read More

Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.